Antidepressants: Education and Disability Certificates
March 22, 2021 | 38 Comments

This post covers difficulties primarily on antidepressants that medicines can cause to people in schools or universities who end up unable to study or do course-work, as well as the difficulties people can have trying to get off medicines, a process that can be pretty disabling. The materials linked to this post are being put […]

Read more ....

Covid and the Market in Research
April 13, 2020 | 20 Comments

  There are 3 bits to this post – an interview with Joan-Ramon Laporte.  An article by Ariane Denoyel and a Q and A with Laporte and Healy. Laporte Interview As part of a series for ROAR Magazine, Frank Barat has run some striking interviews about aspects of the Covid pandemic not usually mentioned. Here […]

Read more ....

Medications compromising Covid Infections
April 2, 2020 | 61 Comments

IN THE MIDST OF THE SARS-CoV-2 PANDEMIA, CAUTION IS NEEDED WITH COMMONLY USED DRUGS THAT INCREASE THE RISK OF PNEUMONIA. Joan-Ramon Laporte, M.D. Emeritus Professor of Clinical Pharmacology, Department of Pharmacology, Therapeutics and Toxicology Universitat Autònoma de Barcelona. Fundació Institut Català de Farmacologia. WHO Collaborating Centre for Research and Training in Pharmacoepidemiology. jrl@icf.uab.cat David Healy […]

Read more ....

Fake News and the Great Purple Pill
January 14, 2019 | 14 Comments

Editorial: This post by Johanna Ryan is one of several that will pick up on the Fake News theme.  But we also want anyone who has PPI stories to get in touch.  And to pick up Dee Mangin’s legacy prescribing issue, do PPIs lead to SSRI use or is it the other way around?  There […]

Read more ....

Support our RxISK Prize campaign